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Integrating emotional and psychological
support into the end-stage renal disease
pathway: a protocol for mixed methods
research to identify patients’ lower-level
support needs and how these can most
effectively be addressed
Francesca Taylor1* , Celia Taylor2, Jyoti Baharani3, Johann Nicholas4 and Gill Combes1
Abstract
Background: As a result of difficulties related to their illness, diagnosis and treatment, patients with end-stage renal
disease experience significant emotional and psychological problems, which untreated can have considerable negative
impact on their health and wellbeing. Despite evidence that patients desire improved support, management of their
psychosocial problems, particularly at the lower-level, remains sub-optimal. There is limited understanding of
the specific support that patients need and want, from whom, and when, and also a lack of data on what
helps and hinders renal staff in identifying and responding to their patients’ support needs, and how barriers
to doing so might be overcome. Through this research we therefore seek to determine what, when, and how,
support for patients with lower-level emotional and psychological problems should be integrated into the end-stage
renal disease pathway.
Methods/Design: The research will involve two linked, multicentre studies, designed to identify and consider
the perspectives of patients at five different stages of the end-stage renal disease pathway (Study 1), and
renal staff working with them (Study 2). A convergent, parallel mixed methods design will be employed for
both studies, with quantitative and qualitative data collected separately. For each study, the data sets will be
analysed separately and the results then compared or combined using interpretive analysis. A further stage of
synthesis will employ data-driven thematic analysis to identify: triangulation and frequency of themes across
pathway stages; patterns and plausible explanations of effects.
Discussion: There is an important need for this research given the high frequency of lower-level distress
experienced by end-stage renal disease patients and lack of progress to date in integrating support for their
lower-level psychosocial needs into the care pathway. Use of a mixed methods design across the two studies
will generate a holistic patient and healthcare professional perspective that is more likely to identify viable solutions
to enable implementation of timely and integrated care. Based on the research outputs, appropriate support
interventions will be developed, implemented and evaluated in a linked follow-on study.
Keywords: Emotional, Psychological, Distress, End-stage renal disease, Mixed methods research, Integrated care
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Background
Burden of end stage renal disease
End-stage renal disease (ESRD) is when kidney function
has deteriorated to such a poor level that without renal
replacement therapy (RRT), dialysis or transplantation,
death is probable within weeks or months. While dialysis
and renal transplantation are life-saving treatments, they
are also demanding and impact appreciably on the
everyday lives of ESRD patients, often negatively affect-
ing emotional and psychological wellbeing. Many pa-
tients find the transition to dialysis frightening and
traumatic [1–3]. They can continue to experience pe-
riods of distress throughout their time on dialysis, due
to the stress of treatment, loss of sexual function, altered
body image, and decreased physical and cognitive func-
tioning, as well as knock-on effects for employment, re-
lationships and lifestyle [4–6]. Transplant patients
experience many of the same stresses, along with fear of
transplant failure and significant distress if a transplant
does fail [7].
The prevalence of depression or anxiety in the ESRD
population is around four times higher than in the gen-
eral adult population [8–10]. No robust data exist on the
prevalence of lower-level emotional and psychological
problems, defined as difficulties in coping effectively
with diagnosis, physical symptoms and treatment, which
result in distress, poor emotional adjustment and re-
duced quality of life [11, 12]. Nonetheless, a recent study
found that more than a third of dialysis patients experi-
enced emotional difficulties [3]. Furthermore, untreated
lower-level problems are associated with withdrawal
from dialysis treatment [13, 14]; poor medication and
diet compliance [15–17]; and, reduced ability to engage
in pre-RRT education and treatment choice [3, 18, 19].
Patient support
During the last 10 years several national policy docu-
ments have highlighted the importance of meeting renal
patients’ emotional and psychological needs [20–22].
Support for patients’ psychosocial needs is integral to
the recommended management of all long-term condi-
tions [23]. Policy also emphasises that mental health
should have parity with physical health and be integrated
into care pathways [24, 25].
Despite this supportive policy framework and the evi-
dence that patients with ESRD have significant needs,
management of patients’ emotional and psychological
difficulties, particularly at the lower-level, remains sub-
optimal. Access to support is often restricted to patients
with higher-level needs requiring psychiatric or psycho-
logical interventions. Patients want improved lower-level
support, particularly in the areas of coping and adjust-
ment [18, 26, 27], yet their needs tend to be ignored and
frequently remain untreated [18, 26, 28].
Adjustment to ESRD has been described as a dynamic
and constant process rather than an experience with an
end point [29]. Across the ESRD pathway, patients are
regularly faced with different emotional stressors and
changes to their health. However, there appear to be cer-
tain ‘crisis points’ or ‘transitions’ that generate particu-
larly strong stressors, such as first diagnosis of ESRD
and initiation of dialysis [1, 2, 27]. This suggests there
may be potential in exploring further whether there are
key points in the pathway when support needs are
greater and thus where it may be more effective to target
support. There is a lack of studies though, that examine
emotional and psychological responses across the ESRD
trajectory over time.
It has also been argued in the context of chronic dis-
eases in general, that very low or no emotional distress
is not always desirable. In some circumstances such as
receiving a diagnosis, feeling distress may be considered
normal and the absence of distress maladaptive. Distress
is more likely to be problematic if it continues over a
long period. Therefore low or no distress should perhaps
not be the singular outcome of any support interven-
tions. An additional objective should be to impact posi-
tively on the process of adjustment, by helping patients
to manage negative emotions, or to maintain positive
affect in response to stressors [30], particularly since
positive and negative affect can be independent [31].
Adjustment and coping can be fostered by renal staff
helping patients release stressful emotion, develop cop-
ing skills, build healthy emotional responses and re-
establish a balance in their life [32]. This first requires
that staff recognise patients with lower-level emotional
and psychological needs. The apparent high prevalence
of untreated lower-level distress in patients with ESRD
suggests there would be value in some form of system-
atic appraisal or screening being incorporated into the
dialysis and transplantation pathways. Screening in itself
will not lead to better health outcomes, but can help
identify patients whose distress would otherwise remain
undetected [33], and enable targeted provision of appro-
priate evidence-based support interventions.
Given the significant proportion of patients with ESRD
who could potentially benefit from improved support,
the most feasible interventions are likely to be low-cost
and easy to incorporate into everyday clinical practice.
There is a lack of evidence on interventions of this type
used by patients with ESRD, although positive health im-
pacts have been recorded in response to physical exercise
[34–36] and coping and empowerment skills [37, 38].
More substantive evidence within the context of long-
term conditions in general highlights the beneficial
health and wellbeing outcomes of peer support [39];
mindfulness-based therapy [39–41]; and cognitive be-
haviour therapy (CBT)/computerised CBT [39, 42].
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Additionally, interventions that involve patients provid-
ing clinicians with written information about their emo-
tional needs in advance of consultation, or that encourage
patients to ask more questions during consultations, have
been found to promote discussion of emotional issues, im-
proving patients’ wellbeing and reducing anxiety [43–45].
Findings from an earlier linked study suggested that two
different types of low-cost intervention, designed to adjust
consultant-patient communication, both have the poten-
tial to equip consultants with the cognitive and behav-
ioural tools that enable discussion of emotional issues
during routine out-patient consultations with ESRD pa-
tients [27]. The interventions were first, a Patient Issues
sheet on which prior to their consultation, patients could
indicate from the issues shown relating to their illness,
those they would like to talk about. Second, consultants
asking patients a question adapted from the Patient
Health Questionnaire (PHQ-9) [46] recommended by the
National Institute for Health and Care Excellence [47],
about whether they had been feeling down or miserable in
the last week.
Staff attitudes and behaviour
The reasons why renal staff do not identify or respond to
the lower-level emotional and psychological needs of their
patients with ESRD have not been well researched. There
is some evidence that staff find it hard to recognise pa-
tients’ distress [26, 45], while cancer studies suggest many
patients tend not to spontaneously express emotional con-
cerns in clinics [44, 48]. Some patients may feel unable to
disclose their feelings to staff who care for them regularly
[49]. Cultural and ethnic background may also play a crit-
ical role in multicultural patient populations [50]. Add-
itionally, it seems that doctors are reluctant to raise
emotional issues during consultations, preferring to focus
on the biomedical [51, 52]. Discussions with local renal
consultants identified further barriers, including worries
about lengthening consultation times, being unable to deal
with the issues raised by patients, uncertainty about where
to refer patients for support, and added costs.
Nurses and healthcare assistants (HCAs) are particularly
well placed to support ESRD patients as they spend more
time and develop closer relationships with patients, often
over many years. There is an absence of evidence, how-
ever, about what prevents them from addressing patients’
psychosocial needs. Notably, though, there is relevant re-
search conducted in other long-term conditions to indi-
cate that clinicians and health staff in general can be
educated and trained to effectively deliver support to pa-
tients in distress [53, 54].
Local context
Several local NHS Trusts have expressed interest in
implementing low-cost interventions to better support
the psychosocial needs of their ESRD patients. However,
renal clinicians from the Trusts recognise that to facili-
tate implementation it will be important to accurately
target appropriate interventions towards those patients
for whom the need is greatest, and when and where in
the ESRD pathway effect is likely to be strongest. Add-
itionally, it is acknowledged that existing barriers to
renal staff identifying and responding to patient needs
will have to be overcome.
Aims and objectives
While there is robust evidence that ESRD patients have
emotional and psychological needs, there is less data on
the specific support that patients need and want, from
whom, and at which points in the ESRD pathway. We
also have limited knowledge of what helps or hinders
renal staff in identifying and responding to their patients’
needs. Therefore, the overarching aim of the research is
to determine what, when and how support for patients
with lower-level emotional and psychological needs
should be integrated into the ESRD pathway. The re-
search will involve two linked studies.
The aim of Study 1 is to identify what support is
needed and wanted, when, and by which ESRD patients
with lower-level emotional and psychological needs. The
objectives are to:
a) Determine whether there are quantifiable differences
in the levels of distress experienced by patients at
different points in the ESRD pathway
b) Explore ESRD patients’ needs, wants and expectations
of support for lower-level emotional and psychological
difficulties
c) Determine whether there are patient groups who
need and want more support than others for lower-
level emotional and psychological difficulties
d) Explore whether there are certain points along the
ESRD pathway when patients should be screened for
emotional distress and offered support interventions
e) Assess which interventions could potentially help
most, for whom, and under which circumstances.
For Study 2, the aim is to assess what helps or hinders
renal staff in identifying and responding to ESRD pa-
tients with lower-level emotional and psychological
needs, and how barriers to doing so might be overcome.
The objectives are to:
a) Explore staff views about what support is required
for patients at key points in the ESRD pathway and
when this support might be needed most
b) Explore what staff think are the components of good
support for lower-level emotional and psychological
needs and whose role it is to meet these needs
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c) Detail how patients with lower-level emotional and
psychological needs are currently identified, how
these are supported and by whom
d) Determine what factors help or hinder staff in
identifying and responding to patients’ lower-level
emotional and psychological needs
e) Explore what interventions, tools, resources, training
and support are needed to improve how staff identify
and respond to patients’ lower-level emotional and
psychological needs
f ) Identify and explain differences and similarities between
sites, including how local context influences practice.
The intelligence collected from the two studies will be
used to develop a theoretical model for collaborative care
management in ESRD that can aid local renal staff in
designing and targeting appropriate low-cost, evidence-
based interventions to support patients’ lower-level emo-
tional and psychological needs. Based on this model, local
staff will develop appropriate interventions for implemen-
tation and evaluation in a planned follow-on study. The
results from Studies 1 and 2 will also provide a baseline
against which future patient and staff views can be
assessed after implementation of the interventions.
Methods/Design
Funding and governance
The research is funded by the National Institute for
Health Research (NIHR) programme, Collaborations for
Leadership in Applied Health Research and Care West
Midlands (CLAHRC WM). The conduct of the research
will be overseen by an Advisory Group which will meet at
4-monthly intervals throughout the research programme
and includes renal clinicians, psychologists, academics,
the Principal Investigators (PIs), and a home haemodialy-
sis (HHD) patient.
Setting
Studies 1 and 2 will be undertaken in two Renal Centres
in the West Midlands. The sites recruited into the study
have variable ESRD patient populations (see Table 1);
psychological support services; current interventions to
support ESRD patients with lower-level emotional and
psychological needs and organisation of dialysis and
transplant services.
Overview of design
A convergent, parallel mixed methods design [55] will be
employed for both studies. Mixed research methods (com-
bined qualitative and quantitative) have been chosen be-
cause of the key benefits of triangulation: providing
context, illustration, completeness and credibility [56]. A
mixed methods design is also particularly useful in the de-
velopment and subsequent evaluation of a complex inter-
vention [57]. Qualitative and quantitative data will be
collected separately. For each study, both data sets will be
analysed separately and the results then compared or
combined using interpretive analysis.
A further stage of synthesis will use data-driven the-
matic analysis [58] to describe and interpret findings,
looking for: triangulation of themes from multiple data
sources; frequency of themes across pathway stages; pat-
terns and plausible explanations of observed effects. We
will also explore generalisability through a more in-
depth exploration of the qualitative data, as used by
Gillard et al. [59], to consider whether findings reflect
localised issues that are context-specific, or whether
they are likely to apply to all ESRD pathways.
Participants
Patients at five different points across the ESRD path-
way, and renal staff working with them, will be studied.
Existing evidence, and discussion with clinicians in the
study sites, indicates that ESRD patients are likely to ex-
perience different types and levels of distress at five key
stages of the pathway. The five stages are (1) diagnosed
with chronic kidney disease (CKD) stage 5 and still pre-
RRT; (2) on dialysis (peritoneal dialysis [PD], haemodi-
alysis [HD], or HHD) for less than 2 years, and not on
the transplant list; (3) on dialysis for more than 2 years,
and not on the transplant list; (4) on dialysis and on the
transplant list; and (5) with functioning transplant.
Table 1 Numbers of patients at each stage of ESRD pathway
Study site 1 Study site 2 Total 40 % response rate
Pre-dialysis 180a 180a 360 144
On dialysis less than 2 years, not on transplant list 114 111 225 90
On dialysis more than 2 years, not on transplant list 213 259 472 189
On dialysis and on transplant list 56c 106c 162 65
With transplant for any time period 180b 182b 362 145
Total all stages 743 838 1581 633
Sources: Estimates based on figures from Renal Registry, 2014 (Tables 1.4, 5.9, 5.11); aTrust figures, September 2015; bRenal Registry, 2014 (Table 2.2.); c Estimates
based on figures from Renal Registry, 2013 (Tables 2.2 and 4.2) and Renal Registry, 2014 (Tables 1.4 and 2.2)
Taylor et al. BMC Nephrology  (2016) 17:111 Page 4 of 12
Literature review
A summary literature review will be conducted using so-
cial science based literature published in the UK and
internationally from studies undertaken among patients
with ESRD and renal staff who work with them. Studies
will also be included that have involved patients with
other comparable long term conditions and at similar
disease stages (advanced/severe/end stage/incurable),
and staff who work with them: for example, end-stage
chronic obstructive pulmonary disease, advanced cancer,
chronic disease at palliative end of life care.
Publications will be surveyed from 1995 to 2015.
Searches will be undertaken of the following databases:
MEDLINE, Embase, PsychINFO, CINAHL, Cochrane
Library, Web of Science.
The literature review will address these specific re-
search questions:
1. Which interventions to support lower-level emotional
and psychological needs are likely to help most, and
for whom, under which circumstances?
2. Are there any generic low-cost interventions that
might be adopted for use with all ESRD patients?
3. Are there interventions that can provide support for
renal staff negatively affected by supporting the
emotional needs of ESRD patients?
Patient and public involvement
The research design has been driven from the start by
renal patients’ needs. The idea for the research study
came from listening to ESRD patients at a half-day
Workshop held in June 2014 attended by 32 patients
and renal clinicians. The Workshop aims were to
present and reflect on findings from an earlier linked
study of two interventions designed to prompt discus-
sion of emotional issues during outpatient consultations
[27], and brainstorm ideas for future research. The pri-
ority research areas identified by patients were to ex-
plore: which interventions to support emotional needs
best suit which types of ESRD patient; how renal staff
can be encouraged and enabled to support patients’
emotional needs.
Several patients attending the Workshop volunteered
to be members of a renal patient and public involvement
(PPI) reference group. They have been closely involved
in the design of this research and will remain actively in-
volved throughout the work, contributing their perspec-
tives on emerging and final research findings and how
these should be disseminated and implemented. In
addition, the researchers will continue to work closely
with a CLAHRC PPI Forum that meets every three
months. The four PPI Forum advisors have contributed
to the design of the study questionnaires and interview
topic guides, and will review and disseminate study
findings. This process will ensure the research outputs
have relevance and benefit to patients.
Study 1: patients
Participant inclusion and exclusion criteria
Inclusion
1. Adult patients aged 18 years and over, receiving
treatment at one of the study sites, with a diagnosis
of CKD stage 5 and at one of the identified five key
stages of the ESRD pathway.
2. Clinically stable and well enough to take part.
3. Have the capacity to give informed consent.
4. Willingness to take part.
5. Not had contact with psychiatric services (including
seeing a psychiatrist) since diagnosis with CKD stage 5.
Exclusion
1. Lacking capacity to give informed consent.
2. Had contact with psychiatric services (including seeing
a psychiatrist) since diagnosis with CKD stage 5.
Quantitative data
Sampling
Patients who meet the inclusion criteria will be grouped
according to the five identified stages of the ESRD path-
way. Estimated numbers of eligible patients at each of
these stages in the two study sites are shown in Table 1.
Assuming a questionnaire response rate of 40 %, based
on previous patient surveys in these sites, we could
achieve the sample sizes shown in the last column.
Given the relatively low patient numbers at two of the
stages, we propose inviting all patients who meet the
study inclusion criteria to complete the questionnaire in
the study sites (743 patients in site 1, 838 patients in site 2).
Recruitment
A Renal Unit staff member in each study site will identify
all eligible ESRD patients from patient lists. These patients
will be sent a questionnaire ‘pack’ by the lead consultant
of their Renal Unit, containing a letter about the study, a
hard copy questionnaire and pre-paid reply envelope ad-
dressed to a study researcher at the University. Addition-
ally, the pack will include a Study Information Sheet,
outlining the study purpose and what participation will in-
volve, with contact details for a study researcher if there
are any queries about the study, and for nurse support if a
patient participant is feeling distressed or upset. The
Information Sheet will also suggest that patients with
language difficulties ask someone they know to help
them complete the questionnaire.
To help maximise the response rate, patients that have
not returned the questionnaire after three weeks will be
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sent another questionnaire pack. In order to identify
these patients while also maintaining patient anonymity,
the study researchers will mark each envelope contain-
ing the questionnaire pack with a different number, plus
an initial indicating the study site. They will mark the
same number and initial on the enclosed reply-paid en-
velope. Each study site will be sent the appropriate ques-
tionnaire packs for despatch. The renal staff member in
each site assigned to addressing and despatching the
packs to eligible patients, will then record the relevant
number on their patient list. Three weeks after the ques-
tionnaire packs have been sent to patients, the study re-
searchers will collate all the numbers on returned
envelopes and then inform the relevant staff member of
the returned numbers for their site. The staff members
will then know, by comparing the returned numbers to
the numbers recorded on their patient list, which pa-
tients have not returned a completed questionnaire and
therefore should be sent a second pack.
Data collection
All patients in the study sample will be invited to
complete a self-report questionnaire (Additional file 1).
The questionnaire will include validated measures for
assessing different aspects of emotional distress, and
adjustment to emotional stressors, in combination with
additional questions about emotional support and inter-
vention use. We have deliberately chosen short validated
measures, which together with the additional questions,
should not take longer than 20 min to complete and avoid
over-burdening patients.
Measures employed in the study and rationale
a) Validated measures
The Distress Thermometer (DT) [60] has been se-
lected as the primary measure of distress for this study;
and will be used to enable comparisons of the level of
distress at different stages in the ESRD pathway and
how support needs vary at different levels of distress.
There are few validated tools for measuring emotional
and psychological needs at the lower-level among ESRD
patients, or chronic disease patients in general. Existing
studies have tended to use validated tools designed to
measure anxiety and depression e.g. the Hospital Anxiety
and Depression Score (HADS), the Beck Depression In-
ventory (BDI, BDI-1A, BDI-11), looking for scores below
the thresholds set for detecting the clinical presence of
anxiety or depression. An advantage of these tools is that
they are reliable measures, validated for use with renal pa-
tients. However, they appear to restrict lower-level emo-
tional issues to those linked with low-level anxiety and
depression, and therefore, are not suitable for this study
which uses a broader definition, encompassing a range of
symptoms, emotions and experiences associated more
with distress (see Background).
There are two main tools which have been developed
to measure distress: the Brief Symptom Inventory (BSI)
and the more recently designed DT. The DT is a meas-
ure of global distress initially developed by Roth et al.
[60] for the National Comprehensive Cancer Network
(NCCN). The term ‘distress’ was chosen by NCCN be-
cause it is “more acceptable and less stigmatizing than
‘psychiatric’, ‘psychosocial’ or ‘emotional’, sounds ‘normal’
and less embarrassing, and can be measured by self-report”
[61]. Although developed for cancer patients, the DT has
been validated for use in a range of chronic disease popula-
tions, including more recently a UK renal population [62].
Furthermore, being a visual measure makes the DT particu-
larly helpful for people with language difficulties [39].
In cancer populations, a score of 4 or 5 (on a 0–10
scale) on the DT is defined as mild distress, a score of 6
or 7 as moderate distress, and 8 or higher as severe dis-
tress [63]. For this study, we will classify ESRD patients
who score between 4 and 7 on the DT as having lower-
level emotional and psychological problems. A problem
list accompanies the DT to identify causes for distress
and this will also be included in the study questionnaire.
We will use the DT contained within the Emotion
Thermometers (ET) [63, 64]. The ET is a simple five-
domain visual analogue scale. Each domain is self-rated
on an 11-point (0 to 10) Likert scale. In addition to the
Distress Thermometer, it contains the Anxiety, Depres-
sion, Anger, and Help Thermometers. Patients score
these thermometers on the basis of how much emo-
tional upset they have experienced during the preceding
week, including the present day. Containing a combin-
ation of items, the ET has been found with cancer pa-
tients to be more accurate than a single domain for the
identification of any significant emotional difficulty, as
well as the assessment of broadly defined distress; 51 %
of patients who scored below the cut-off point for dis-
tress using the DT recorded emotional difficulties on the
ET [64]. Furthermore, the ET is very quick to complete
(less than one minute) with non-completion rates low in
comparison with conventional measures [63, 64].
The Positive and Negative Affect Schedule [PANAS]
will be used to measure patients’ adjustment to emo-
tional stressors. Developed and validated by Watson
et al. [32], this 20-item instrument that measures posi-
tive and negative affect has been widely used in different
chronic disease populations and some renal populations
[65]. Positive Affect (PA) reflects the extent to which a
patient feels enthusiastic, active and alert, while the
Negative Affect (NA) dimension assesses subjective dis-
tress and discomfort. PA and NA have high internal
consistency and are largely uncorrelated [32].
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Each item of the PANAS is rated on a 5-point scale to
indicate the extent to which the respondent has felt this
way in general or a specific time-period such as ‘in the
past few hours’ or ‘during the past week’. We will use a
time period of ‘during the last week’.
b) Additional measures
Patients’ perceptions and views will also be measured
on: recent events that have caused distress; ability to
cope with their illness and treatment; extent to which
feel supported by renal staff; interventions used for dis-
tress; benefits and satisfaction from receiving support for
distress from renal staff; practical ideas about future sup-
port for distress.
Most of these questions will have pre-set answer op-
tions using an 11-point (0–10) Likert response scale
[66]. Negatively and positively worded answer options
will be balanced to avoid ‘yea’ saying’. An open-ended
question at the end will allow free-text responses, to
avoid missing any types of support considered important
through use of pre-set answer options. Tick-box data
will be collected on age, gender, ethnicity, relationship
status, length of time since diagnosis, length of time on
dialysis or with a functioning renal transplant, and dialysis
treatment type. Patients will also be asked whether they
received any assistance in completing the questionnaire.
Additionally, respondents will be asked if they are willing
to participate in a further individual telephone or face-to-
face interview, and if so to provide their contact details.
Sample size calculation
The sample size calculation – based on the study objective
to determine whether there are any differences in distress
at different stages of the ESRD pathway - assumes a
1.5-point difference on the DT between patient
groups (pathway stages) with the largest and smallest
means. A two-sided alpha of 0.05 and 90 % power
have been used. This gives an effect size, f, of 0.20. A
sample size calculation (using G*Power version 3.1.9.2)
gives a total sample size of 485, approximately 97 in each
patient group across the two study sites. Since group sizes
will not be equal, ideally this would be the sample
size requirement for the smallest group, although it is
noted that this may not be met in practice for all
groups (see Table 1).
Analysis
One-way ANOVA will be used to analyse data from the
DT, ET, and PANAS, combining data across both sites.
If there is a statistical significant difference on the main
analysis measure, the DT, between patients at different
stages on the ESRD pathway, then appropriate post-hoc
t-tests to compare individual patient groups will be
undertaken, with p-values corrected for multiple compari-
sons using the Bonferroni Adjustment. Comparisons of
scores between patient groups and study sites will be
made using two-way ANOVA, although we may not have
sufficient power to detect small differences between sites.
The remaining questionnaire data, although on Likert
scales, will initially be analysed as continuous data, using
means and standard deviations or medians and inter-
quartile ranges as appropriate for the distribution. Scores
from individual items in each question-group will be
summed prior to analysis e.g. to give a composite
‘coping’ score. Appropriate corrections for multiple
comparisons will be made given that multiple ques-
tions are being asked.
Qualitative data
Sampling
Sampling will be purposive, based on the study inclusion
criteria and to provide maximum diversity of age, gender,
ethnicity, and stage in the ESRD pathway. The aim is to
conduct 25 interviews - five interviews with patients at
each of the five stages of the ESRD pathway - in each of
the two study sites, or until thematic saturation is
achieved. Refusal rates have varied widely, between 30 and
69 %, for recent studies in ESRD patient populations
undertaken by the study researchers in the study sites
[3, 29]. Therefore, to achieve this sample size, an ini-
tial sample of 85 patients – 17 patients at each of the
five stages of the ESRD pathway - will be drawn up
in each site.
Recruitment
This will be undertaken from amongst two patient groups.
First, patients who have completed the questionnaire,
scored between 4 and 7 on the DT, and expressed a
willingness to participate in a telephone or face-to-
face interview. Second, patients who have completed the
questionnaire, scored less than 4 on the DT but between 4
and 7 on any of the other Emotion Thermometers, and
expressed a willingness to participate in an interview.
A study researcher will send these patients a Consent
Form, together with a Study Information Sheet outlining
the study purpose and what participation will involve. It
will also include the same contact details as provided in
the questionnaire Information Sheet. Patients would be
contacted by phone at least 7 days later by a study re-
searcher, and a suitable date and time arranged for inter-
view with those who consent to participate. Translation
and interpretation facilities will be made available for
participants who may have difficulties in adequately un-
derstanding written and verbal information in English.
For all patients, written consent will be taken by a study
researcher prior to the start of the interview.
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Data collection
The interviews will be in-depth and semi-structured,
allowing key issues to be explored without being
overly prescriptive about content and direction. An
interview topic guide has been developed to cover the
following areas:
a) Experience of emotional difficulties and needs linked
to their illness and/or treatment, when and for how
long.
b) Language used around emotional difficulties and
needs, and its meaning.
c) Whether and how emotional needs have been
recognised and supported by renal staff, when,
and by whom.
d) What, if any, support used, when and why.
e) Likes and dislikes of support used.
f ) Support would have liked/would want in future,
when, and from whom.
g) Key elements would want included in an emotional
support intervention.
Individual face-to-face interviews will be conducted
in each patient’s Hospital Trust, in a quiet room
away from the Renal Unit, where confidentiality is
assured. Telephone interviews will be conducted in a
sound-proof room on University premises. The inter-
views will last 35–45 min and be audio-recorded.
Field notes will be taken to record key thoughts and
issues. Audio-recordings will be professionally tran-
scribed in full and transcripts proof-read against the
recordings.
Analysis
The interviews will be analysed using thematic ana-
lysis [67]. The analysis will be guided by the overall
aims and objectives of the study, supplemented by the
researchers’ identification of themes based on the
views and experiences of patients. At least two re-
searchers will independently analyse and code tran-
scripts from a sub-sample of a minimum of a third of
the interviews. The results will be compared, dis-
cussed and reviewed until agreement is reached. An
initial framework of themes will then be developed,
together with a code book, and used to structure ver-
batim responses onto a spreadsheet. The codes and
themes will be refined and elaborated collectively as
more data is collected. As sequential analysis pro-
gresses, significant data will be compressed so as to
adhere around key analytic themes. Where the data
collected does not fit into existing themes, new
themes will be developed or existing ones revised
until all the data is coded by theme.
Study 2: renal staff
Participant inclusion and exclusion criteria
Inclusion
1. Staff currently working with patients at one of the
five stages of the ESRD pathway, or staff with a renal
managerial role.
2. Employed by the hospital/sub-contractor at one of
the study sites for a minimum of two months.
Exclusion
1. Agency or bank staff.
Design and framework
The study draws on theoretical perspectives linked to
the implementation of change within healthcare. This is
relevant because staff report difficulties in implementing
long-standing national guidance which recommends the
provision of emotional and psychological support for pa-
tients with ESRD. In particular, we have focused on the
research of Oxman [68], Ferlie and Shortell [69], and
Grol and Grimshaw [70], who have similar frameworks
for analysing factors that help or hinder the implementa-
tion of change. Our analytical framework will identify
factors operating at three levels: the individual staff
member (e.g. skills or confidence); the team or Renal
Unit (e.g. time or training); and the organisation or
Hospital Trust as a whole (e.g. resources). This framework
will enable us to develop a detailed understanding of what
helps or hinders staff in identifying and responding to pa-
tients with lower-level emotional and psychological diffi-
culties and insight into what tools, resources, training and
support are effective, and for which staff, to help improve
support for patients.
Quantitative data
Sampling
All staff in the two participating study sites who meet
the inclusion criteria will be invited to complete the on-
line questionnaire: site 1–165 staff; site 2–188 staff. On
the basis of previous staff surveys in these sites, we an-
ticipate around a 70 % response rate. This would result
in approximately 247 returns (115 site 1; 132 site 2).
Recruitment
Staff will be sent an email about the study by their site
clinical lead, with a Study Information Sheet explaining
the study purpose, why they are being asked to take part
in the study, and what participation will involve. It will
also provide contact details for a study researcher if
there are any queries about the study, and for the Trust
Counselling Service, if a staff participant is feeling dis-
tressed or upset. The email will contain a direct web-
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link to access the questionnaire online. If three weeks
after the initial email to staff, response rates are lower
than the anticipated 70 %, a reminder e-mail will be
sent.
Data collection
The questionnaire (Additional file 2) will survey staff
views about the following issues in relation to ESRD pa-
tients with lower-level emotional and psychological needs:
a) Perception of the proportion of all ESRD patients in
their Renal Unit with lower-level needs.
b) Perceived benefits and difficulties of identifying and
responding to patients’ needs.
c) Level of satisfaction with how patients’ needs are
currently met.
d) Extent to which the identification and response to
patients’ needs is seen as part of current role, and
who else has responsibility for this in the Renal
Unit (‘role’).
e) How skilled, confident and well trained they feel to
identify and respond to patients’ needs (‘capacity’).
f ) Practical ideas about what could help in identifying
and responding to patients’ needs in future.
The two dimensions of ‘role’ and ‘capacity’ have been
selected as the primary outcome measures for this study.
Existing evidence suggests that these two dimensions are
likely to encompass the key issues which help or hinder
renal staff in identifying and responding to the lower-
level emotional and psychological needs of ESRD pa-
tients (see Background – Staff attitudes and behaviour).
A self-completion questionnaire will be used for ease
of response, taking about 10 min to complete, with most
questions having pre-set answer options using an 11-
point (0–10) Likert response scale [66]. Negatively and
positively worded answer options will be balanced to
avoid ‘yea-saying’. Open-ended questions at the end will
allow free-text responses in order to avoid missing issues
through the use of pre-set answer options. Tick-box data
will be collected for respondents’ age, gender, role, fre-
quency of ESRD patient contact, and length of time in
post and since qualification. Additionally, respondents
will be asked if they are willing to participate in a further
individual telephone or face-to-face interview, and if so
to provide their contact details.
Analysis
The data will be analysed as continuous data, using
means and standard deviations or medians and inter-
quartile ranges as appropriate for the distribution. Scores
from individual items in each question-group will be
summed prior to analysis e.g. to give composite ‘role’
and ‘capacity’ scores.
Qualitative data
Sampling
Purposive sampling will select interviewees from staff
completing the questionnaire who have expressed a will-
ingness to participate in a telephone or face-to-face
interview, and based on: role, gender, time in current
post and since qualification. An initial sample of 22 staff
per site will be drawn up, with interviews conducted
until saturation is achieved, provided all staff groups
have been included. This is expected to be achieved with
18–20 staff per site, based on previous qualitative staff
research in the study sites, where the refusal to partici-
pate rate was only 13 % [3]. We therefore expect to have
a total sample size of 36–40 staff. Each site’s sample is
expected to include: 3 consultants; 1 registrar; 6 nurses
and 6 HCAs selected from clinical areas: pre-dialysis,
transplant, unit HD, HHD, PD, wards; 1 dietician; 1
technician; 1 psychologist/counsellor/social worker/wel-
fare advisor; 1 Renal Unit manager. Precise numbers in
each category may vary between sites. The majority of
the sample will be made-up of nurses and HCAs, since
these staff members have most contact with patients,
and an in-depth understanding is needed about why they
are not identifying and responding to their patients’
emotional and psychological needs.
Recruitment
Staff that have completed the questionnaire and expressed
a willingness to participate in a telephone or face-to-face
interview will be sent a Consent Form and Study Informa-
tion Sheet by a study researcher. The Information Sheet
will explain the purpose of the interview, and what partici-
pation will involve, and include the same contact details
as provided in the questionnaire Information Sheet. Staff
would be contacted by phone at least 7 days later by a
study researcher, and a suitable date and time arranged for
interview with those who consent to participate.
In addition, staff that have completed the question-
naire but not answered the question about being willing
to participate in a telephone or face-to-face interview
will be sent an email by the lead consultant of their
Renal Unit, along with a Consent Form and Study Infor-
mation Sheet. The email will explain that a designated
member of staff from their Renal will contact them the
following week to ask whether they were interested in
participating in an individual telephone or face-to-face
interview, and if willing, a suitable date and time for
interview arranged. Contact details of staff willing to
participate in the study would then be provided to the
study researchers.
Data collection and analysis
The interviews will be in-depth and semi-structured,
and conducted in the same locations employed for the
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Study 1 patient interviews. They will be used to explore
and seek explanations of staff attitudes, perceptions and
perspectives; to determine how barriers to staff identify-
ing and responding to the emotional needs of ESRD pa-
tients can be overcome; and, how appropriate changes
can be implemented. An interview topic guide has been
developed to cover the following areas in relation to
ESRD patients with lower-level emotional and psycho-
logical needs:
a) How are patients’ needs identified and supported
(by individual, team/Renal Unit, organisation/
Hospital Trust)
b) Perceptions of the individual/team-Renal Unit/
Hospital role in identifying and responding to
patients’ needs
c) What factors currently help or hinder identification
and support of patients’ needs.
d) Views on the components of good lower-level emo-
tional and psychological support.
e) How skilled, confident and well trained do they feel
to identify and support patients.
f ) What needs to change or improve to enable better
identification and support of patients (interventions,
tools, resources, training, support).
g) Views on how these changes or improvements can
best be facilitated and effectively implemented.
The data collected will be analysed using the same meth-
odological approach as the Study 1 patient interviews.
Discussion
This is important and challenging research since the
management of lower-level emotional and psychological
difficulties experienced by patients with ESRD remains
sub-optimal, despite patients’ desire for improved psycho-
social support and an encouraging policy background.
However, the use of a mixed methods approach across the
two research studies, incorporating qualitative and quanti-
tative components, will generate a holistic perspective that
is more likely to identify viable solutions, enabling inte-
grated care for patients to be incorporated into the ESRD
pathway. By considering the perspectives of both the
ESRD patient and the healthcare professional, it should be
possible to develop interventions that are useful to pa-
tients, but feasible to implement when taking into account
professional and organisational barriers. Based on the re-
search outputs, appropriate interventions to support
ESRD patients with lower-level emotional and psycho-
logical needs will be developed, implemented and evalu-
ated in a linked follow-on study. We aim to disseminate
the research findings through PPI groups involved in the
work, renal peer-reviewed scientific journals, local patient
and clinician workshops, and national conferences.
Additional files
Additional file 1: Patient questionnaire. Questionnaire developed for
Study 1. (PDF 1007 kb)
Additional file 2: Staff questionnaire. Questionnaire developed for
Study 2. (PDF 2781 kb)
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